The GEPIA database revealed that FAM107A expression was reduced in PCa tissues, and survival analysis revealed that high levels of FAM107A expression were associated with a favorable OS rate in patients with prostate cancer. This evidence concerns the gene FAM107A and prostate carcinoma.